No Data
No Data
Nutriband CEO Still Sees Aversa Fentanyl Regulatory Approval Within 2025
Express News | Nutriband Inc: Targeting to File for FDA Approval for Aversa™ Fentanyl in First Half of 2025
10-Q: Q3 2025 Earnings Report
Express News | Nutriband Q3 EPS $(0.12) Up From $(0.22) YoY, Sales $645.80K Up From $427.84K YoY
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session
No Data